Table 5

Optical coherence tomography findings associated with target lesion failure (unadjusted)

Event rateHazard ratio (95% CI)P-value
Minimal stent area, mm2
 <5.24 (median)81/1063 (7.6)Reference
 ≥5.2449/1065 (4.6)0.59 (0.42–0.85).004
Minimal stent expansion, %
 <79.1 (median)78/1063 (7.3)Reference
 ≥79.152/1065 (4.9)0.65 (0.46–0.93).02
Intra-stent flow area, mm2
 <5.14 (median)82/1061 (7.7)Reference
 ≥5.1448/1067 (4.5)0.57 (0.40–0.81).002
Total flow area, mm2
 <5.23 (median)82/1058 (7.8)Reference
 ≥5.2348/1070 (4.5)0.57 (0.40–0.81).002
Stent length, mm
 <33.4 (median)58/1056 (5.5)Reference
 ≥33.472/1072 (6.7)1.24 (0.88–1.76).22
Plaque or thrombus protrusion
 None63/1034 (6.1)Reference
 Any67/1094 (6.1)1.00 (0.71–1.41)1.00
  Major11/147 (7.5)1.22 (0.64–2.31).55
  Minor56/947 (5.9)0.97 (0.67–1.39).85
Mal-apposition
 None48/766 (6.3)Reference
 Any82/1362 (6.0)0.96 (0.67–1.37).83
  Major38/549 (6.9)1.11 (0.73–1.70).62
  Minor44/812 (5.4)0.86 (0.57–1.30).48
Stent deformation or fracture
 None128/2107 (6.1)Reference
 Any2/21 (9.5)1.50 (0.37–6.07).57
Proximal or distal reference disease
 None91/1608 (5.7)Reference
 Any39/513 (7.6)1.36 (0.93–1.98).11
  Focal24/326 (7.4)1.31 (0.84–2.06).23
  Diffuse18/210 (8.6)1.54 (0.93–2.55).10
Proximal reference disease
 None87/1674 (5.2)Reference
 Any19/230 (8.3)1.63 (0.99–2.68).053
  Focal14/170 (8.2)1.62 (0.92–2.85).09
  Diffuse5/60 (8.3)1.66 (0.67–4.09).27
Distal reference disease
 None100/1746 (5.7)Reference
 Any26/343 (7.6)1.34 (0.87–2.06).19
  Focal11/177 (6.2)1.09 (0.58–2.03).79
  Diffuse15/166 (9.0)1.60 (0.93–2.76).09
Proximal or distal reference lipidic plaque
 None114/1767 (6.5)Reference
 Any16/355 (4.5)0.69 (0.41–1.17).17
Proximal reference lipidic plaque
 None100/1683 (5.9)Reference
 Any9/238 (3.8)0.63 (0.32–1.25).19
Distal reference lipidic plaque
 None119/1950 (6.1)Reference
 Any7/144 (4.9)0.79 (0.37–1.70).55
Proximal or distal reference dissection
 None81/1430 (5.7)Reference
 Any49/695 (7.1)1.26 (0.88–1.79).21
 Major4/66 (6.1)1.06 (0.39–2.89).91
 Minor45/629 (7.2)1.28 (0.89–1.84).19
 Intimal17/264 (6.4)1.15 (0.68–1.94).60
 Medial36/460 (7.8)1.40 (0.94–2.07).10
  Haematoma7/71 (9.9)1.75 (0.81–3.79).16
  No haematoma30/398 (7.5)1.35 (0.89–2.05).16
 Adventitial0/3 (0.0)Not applicable.98
Proximal reference dissection, any
 None79/1579 (5.0)Reference
 Any37/418 (8.9)1.80 (1.22–2.66).003
 Major3/34 (8.8)1.81 (0.57–5.72).32
 Minor34/384 (8.9)1.80 (1.21–2.69).004
 Intimal16/188 (8.5)1.74 (1.02–2.97).04
 Medial21/229 (9.2)1.86 (1.15–3.01).01
  Haematoma3/25 (12.0)2.43 (0.77–7.68).13
  No haematoma18/204 (8.8)1.79 (1.08–2.99).03
 Adventitial0/1 (0.0)Not applicable.99
Distal reference dissection
 None107/1738 (6.2)Reference
 Any19/371 (5.1)0.84 (0.51–1.36).47
 Major1/32 (3.1)0.49 (0.07–3.48).47
 Minor18/339 (5.3)0.87 (0.53–1.43).58
 Intimal1/89 (1.1)0.18 (0.03–1.29).09
 Medial18/280 (6.4)1.05 (0.64–1.74).84
  Haematoma4/46 (8.7)1.42 (0.52–3.85).49
  No haematoma14/234 (6.0)0.98 (0.56–1.71).95
 Adventitial0/2 (0.0)Not applicable.98
Event rateHazard ratio (95% CI)P-value
Minimal stent area, mm2
 <5.24 (median)81/1063 (7.6)Reference
 ≥5.2449/1065 (4.6)0.59 (0.42–0.85).004
Minimal stent expansion, %
 <79.1 (median)78/1063 (7.3)Reference
 ≥79.152/1065 (4.9)0.65 (0.46–0.93).02
Intra-stent flow area, mm2
 <5.14 (median)82/1061 (7.7)Reference
 ≥5.1448/1067 (4.5)0.57 (0.40–0.81).002
Total flow area, mm2
 <5.23 (median)82/1058 (7.8)Reference
 ≥5.2348/1070 (4.5)0.57 (0.40–0.81).002
Stent length, mm
 <33.4 (median)58/1056 (5.5)Reference
 ≥33.472/1072 (6.7)1.24 (0.88–1.76).22
Plaque or thrombus protrusion
 None63/1034 (6.1)Reference
 Any67/1094 (6.1)1.00 (0.71–1.41)1.00
  Major11/147 (7.5)1.22 (0.64–2.31).55
  Minor56/947 (5.9)0.97 (0.67–1.39).85
Mal-apposition
 None48/766 (6.3)Reference
 Any82/1362 (6.0)0.96 (0.67–1.37).83
  Major38/549 (6.9)1.11 (0.73–1.70).62
  Minor44/812 (5.4)0.86 (0.57–1.30).48
Stent deformation or fracture
 None128/2107 (6.1)Reference
 Any2/21 (9.5)1.50 (0.37–6.07).57
Proximal or distal reference disease
 None91/1608 (5.7)Reference
 Any39/513 (7.6)1.36 (0.93–1.98).11
  Focal24/326 (7.4)1.31 (0.84–2.06).23
  Diffuse18/210 (8.6)1.54 (0.93–2.55).10
Proximal reference disease
 None87/1674 (5.2)Reference
 Any19/230 (8.3)1.63 (0.99–2.68).053
  Focal14/170 (8.2)1.62 (0.92–2.85).09
  Diffuse5/60 (8.3)1.66 (0.67–4.09).27
Distal reference disease
 None100/1746 (5.7)Reference
 Any26/343 (7.6)1.34 (0.87–2.06).19
  Focal11/177 (6.2)1.09 (0.58–2.03).79
  Diffuse15/166 (9.0)1.60 (0.93–2.76).09
Proximal or distal reference lipidic plaque
 None114/1767 (6.5)Reference
 Any16/355 (4.5)0.69 (0.41–1.17).17
Proximal reference lipidic plaque
 None100/1683 (5.9)Reference
 Any9/238 (3.8)0.63 (0.32–1.25).19
Distal reference lipidic plaque
 None119/1950 (6.1)Reference
 Any7/144 (4.9)0.79 (0.37–1.70).55
Proximal or distal reference dissection
 None81/1430 (5.7)Reference
 Any49/695 (7.1)1.26 (0.88–1.79).21
 Major4/66 (6.1)1.06 (0.39–2.89).91
 Minor45/629 (7.2)1.28 (0.89–1.84).19
 Intimal17/264 (6.4)1.15 (0.68–1.94).60
 Medial36/460 (7.8)1.40 (0.94–2.07).10
  Haematoma7/71 (9.9)1.75 (0.81–3.79).16
  No haematoma30/398 (7.5)1.35 (0.89–2.05).16
 Adventitial0/3 (0.0)Not applicable.98
Proximal reference dissection, any
 None79/1579 (5.0)Reference
 Any37/418 (8.9)1.80 (1.22–2.66).003
 Major3/34 (8.8)1.81 (0.57–5.72).32
 Minor34/384 (8.9)1.80 (1.21–2.69).004
 Intimal16/188 (8.5)1.74 (1.02–2.97).04
 Medial21/229 (9.2)1.86 (1.15–3.01).01
  Haematoma3/25 (12.0)2.43 (0.77–7.68).13
  No haematoma18/204 (8.8)1.79 (1.08–2.99).03
 Adventitial0/1 (0.0)Not applicable.99
Distal reference dissection
 None107/1738 (6.2)Reference
 Any19/371 (5.1)0.84 (0.51–1.36).47
 Major1/32 (3.1)0.49 (0.07–3.48).47
 Minor18/339 (5.3)0.87 (0.53–1.43).58
 Intimal1/89 (1.1)0.18 (0.03–1.29).09
 Medial18/280 (6.4)1.05 (0.64–1.74).84
  Haematoma4/46 (8.7)1.42 (0.52–3.85).49
  No haematoma14/234 (6.0)0.98 (0.56–1.71).95
 Adventitial0/2 (0.0)Not applicable.98

All subcategories are compared with the reference. Outcomes are presented as number of events during 2-year follow-up/number of the patients at risk on Day 0 (Kaplan–Meier estimated event rates).

CI, confidence interval; OCT, optical coherence tomography.

Table 5

Optical coherence tomography findings associated with target lesion failure (unadjusted)

Event rateHazard ratio (95% CI)P-value
Minimal stent area, mm2
 <5.24 (median)81/1063 (7.6)Reference
 ≥5.2449/1065 (4.6)0.59 (0.42–0.85).004
Minimal stent expansion, %
 <79.1 (median)78/1063 (7.3)Reference
 ≥79.152/1065 (4.9)0.65 (0.46–0.93).02
Intra-stent flow area, mm2
 <5.14 (median)82/1061 (7.7)Reference
 ≥5.1448/1067 (4.5)0.57 (0.40–0.81).002
Total flow area, mm2
 <5.23 (median)82/1058 (7.8)Reference
 ≥5.2348/1070 (4.5)0.57 (0.40–0.81).002
Stent length, mm
 <33.4 (median)58/1056 (5.5)Reference
 ≥33.472/1072 (6.7)1.24 (0.88–1.76).22
Plaque or thrombus protrusion
 None63/1034 (6.1)Reference
 Any67/1094 (6.1)1.00 (0.71–1.41)1.00
  Major11/147 (7.5)1.22 (0.64–2.31).55
  Minor56/947 (5.9)0.97 (0.67–1.39).85
Mal-apposition
 None48/766 (6.3)Reference
 Any82/1362 (6.0)0.96 (0.67–1.37).83
  Major38/549 (6.9)1.11 (0.73–1.70).62
  Minor44/812 (5.4)0.86 (0.57–1.30).48
Stent deformation or fracture
 None128/2107 (6.1)Reference
 Any2/21 (9.5)1.50 (0.37–6.07).57
Proximal or distal reference disease
 None91/1608 (5.7)Reference
 Any39/513 (7.6)1.36 (0.93–1.98).11
  Focal24/326 (7.4)1.31 (0.84–2.06).23
  Diffuse18/210 (8.6)1.54 (0.93–2.55).10
Proximal reference disease
 None87/1674 (5.2)Reference
 Any19/230 (8.3)1.63 (0.99–2.68).053
  Focal14/170 (8.2)1.62 (0.92–2.85).09
  Diffuse5/60 (8.3)1.66 (0.67–4.09).27
Distal reference disease
 None100/1746 (5.7)Reference
 Any26/343 (7.6)1.34 (0.87–2.06).19
  Focal11/177 (6.2)1.09 (0.58–2.03).79
  Diffuse15/166 (9.0)1.60 (0.93–2.76).09
Proximal or distal reference lipidic plaque
 None114/1767 (6.5)Reference
 Any16/355 (4.5)0.69 (0.41–1.17).17
Proximal reference lipidic plaque
 None100/1683 (5.9)Reference
 Any9/238 (3.8)0.63 (0.32–1.25).19
Distal reference lipidic plaque
 None119/1950 (6.1)Reference
 Any7/144 (4.9)0.79 (0.37–1.70).55
Proximal or distal reference dissection
 None81/1430 (5.7)Reference
 Any49/695 (7.1)1.26 (0.88–1.79).21
 Major4/66 (6.1)1.06 (0.39–2.89).91
 Minor45/629 (7.2)1.28 (0.89–1.84).19
 Intimal17/264 (6.4)1.15 (0.68–1.94).60
 Medial36/460 (7.8)1.40 (0.94–2.07).10
  Haematoma7/71 (9.9)1.75 (0.81–3.79).16
  No haematoma30/398 (7.5)1.35 (0.89–2.05).16
 Adventitial0/3 (0.0)Not applicable.98
Proximal reference dissection, any
 None79/1579 (5.0)Reference
 Any37/418 (8.9)1.80 (1.22–2.66).003
 Major3/34 (8.8)1.81 (0.57–5.72).32
 Minor34/384 (8.9)1.80 (1.21–2.69).004
 Intimal16/188 (8.5)1.74 (1.02–2.97).04
 Medial21/229 (9.2)1.86 (1.15–3.01).01
  Haematoma3/25 (12.0)2.43 (0.77–7.68).13
  No haematoma18/204 (8.8)1.79 (1.08–2.99).03
 Adventitial0/1 (0.0)Not applicable.99
Distal reference dissection
 None107/1738 (6.2)Reference
 Any19/371 (5.1)0.84 (0.51–1.36).47
 Major1/32 (3.1)0.49 (0.07–3.48).47
 Minor18/339 (5.3)0.87 (0.53–1.43).58
 Intimal1/89 (1.1)0.18 (0.03–1.29).09
 Medial18/280 (6.4)1.05 (0.64–1.74).84
  Haematoma4/46 (8.7)1.42 (0.52–3.85).49
  No haematoma14/234 (6.0)0.98 (0.56–1.71).95
 Adventitial0/2 (0.0)Not applicable.98
Event rateHazard ratio (95% CI)P-value
Minimal stent area, mm2
 <5.24 (median)81/1063 (7.6)Reference
 ≥5.2449/1065 (4.6)0.59 (0.42–0.85).004
Minimal stent expansion, %
 <79.1 (median)78/1063 (7.3)Reference
 ≥79.152/1065 (4.9)0.65 (0.46–0.93).02
Intra-stent flow area, mm2
 <5.14 (median)82/1061 (7.7)Reference
 ≥5.1448/1067 (4.5)0.57 (0.40–0.81).002
Total flow area, mm2
 <5.23 (median)82/1058 (7.8)Reference
 ≥5.2348/1070 (4.5)0.57 (0.40–0.81).002
Stent length, mm
 <33.4 (median)58/1056 (5.5)Reference
 ≥33.472/1072 (6.7)1.24 (0.88–1.76).22
Plaque or thrombus protrusion
 None63/1034 (6.1)Reference
 Any67/1094 (6.1)1.00 (0.71–1.41)1.00
  Major11/147 (7.5)1.22 (0.64–2.31).55
  Minor56/947 (5.9)0.97 (0.67–1.39).85
Mal-apposition
 None48/766 (6.3)Reference
 Any82/1362 (6.0)0.96 (0.67–1.37).83
  Major38/549 (6.9)1.11 (0.73–1.70).62
  Minor44/812 (5.4)0.86 (0.57–1.30).48
Stent deformation or fracture
 None128/2107 (6.1)Reference
 Any2/21 (9.5)1.50 (0.37–6.07).57
Proximal or distal reference disease
 None91/1608 (5.7)Reference
 Any39/513 (7.6)1.36 (0.93–1.98).11
  Focal24/326 (7.4)1.31 (0.84–2.06).23
  Diffuse18/210 (8.6)1.54 (0.93–2.55).10
Proximal reference disease
 None87/1674 (5.2)Reference
 Any19/230 (8.3)1.63 (0.99–2.68).053
  Focal14/170 (8.2)1.62 (0.92–2.85).09
  Diffuse5/60 (8.3)1.66 (0.67–4.09).27
Distal reference disease
 None100/1746 (5.7)Reference
 Any26/343 (7.6)1.34 (0.87–2.06).19
  Focal11/177 (6.2)1.09 (0.58–2.03).79
  Diffuse15/166 (9.0)1.60 (0.93–2.76).09
Proximal or distal reference lipidic plaque
 None114/1767 (6.5)Reference
 Any16/355 (4.5)0.69 (0.41–1.17).17
Proximal reference lipidic plaque
 None100/1683 (5.9)Reference
 Any9/238 (3.8)0.63 (0.32–1.25).19
Distal reference lipidic plaque
 None119/1950 (6.1)Reference
 Any7/144 (4.9)0.79 (0.37–1.70).55
Proximal or distal reference dissection
 None81/1430 (5.7)Reference
 Any49/695 (7.1)1.26 (0.88–1.79).21
 Major4/66 (6.1)1.06 (0.39–2.89).91
 Minor45/629 (7.2)1.28 (0.89–1.84).19
 Intimal17/264 (6.4)1.15 (0.68–1.94).60
 Medial36/460 (7.8)1.40 (0.94–2.07).10
  Haematoma7/71 (9.9)1.75 (0.81–3.79).16
  No haematoma30/398 (7.5)1.35 (0.89–2.05).16
 Adventitial0/3 (0.0)Not applicable.98
Proximal reference dissection, any
 None79/1579 (5.0)Reference
 Any37/418 (8.9)1.80 (1.22–2.66).003
 Major3/34 (8.8)1.81 (0.57–5.72).32
 Minor34/384 (8.9)1.80 (1.21–2.69).004
 Intimal16/188 (8.5)1.74 (1.02–2.97).04
 Medial21/229 (9.2)1.86 (1.15–3.01).01
  Haematoma3/25 (12.0)2.43 (0.77–7.68).13
  No haematoma18/204 (8.8)1.79 (1.08–2.99).03
 Adventitial0/1 (0.0)Not applicable.99
Distal reference dissection
 None107/1738 (6.2)Reference
 Any19/371 (5.1)0.84 (0.51–1.36).47
 Major1/32 (3.1)0.49 (0.07–3.48).47
 Minor18/339 (5.3)0.87 (0.53–1.43).58
 Intimal1/89 (1.1)0.18 (0.03–1.29).09
 Medial18/280 (6.4)1.05 (0.64–1.74).84
  Haematoma4/46 (8.7)1.42 (0.52–3.85).49
  No haematoma14/234 (6.0)0.98 (0.56–1.71).95
 Adventitial0/2 (0.0)Not applicable.98

All subcategories are compared with the reference. Outcomes are presented as number of events during 2-year follow-up/number of the patients at risk on Day 0 (Kaplan–Meier estimated event rates).

CI, confidence interval; OCT, optical coherence tomography.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close